Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AbleNet is a private U.S. assistive technology and medical device company focused on products and services for people with disabilities, particularly individuals with complex communication needs. The company develops, manufactures, and distributes assistive technology products including speech-generating devices, switches, mounts, access tools, and related software and support services. Its flagship offering is the QuickTalker Freestyle speech device, which the company pairs with insurance funding support, training, and clinical implementation services for speech-language pathologists, schools, and families. AbleNet also provides educational resources and continuing education through ableU, as well as legacy special-education curriculum products such as Equals math. The business is commercial-stage and operates primarily in the U.S., with broader global distribution for parts of its assistive technology portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AbleNet.